TickerSpark Feed

ZTS Coverage

Every TickerSpark article mentioning ZTS — research reports, earnings, trending movements, and macro context.

2 articles

Zoetis (ZTS): Growth Reset, Still a Premium Franchise

Zoetis remains a high-quality animal health leader, but 2026 guidance cuts and softer U.S. companion-animal demand temper the near-term setup. The stock looks like a disciplined Buy with a fair value of $132.

May 7, 2026·23 min read

Healthcare Drug Manufacturers - Specialty & Generic Healthcare

Trending StockZTS

Zoetis Inc. (ZTS) falls 13% after weak Q1 earnings

Zoetis Inc. (ZTS) falls sharply after reporting Q1 2026 results that missed expectations and came with softer full-year guidance. The selloff reflects weaker U.S. revenue, a profit miss, and a market reset for the animal-health leader.

May 7, 2026·5 min read

Want a deeper dive on ZTS?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate ZTS Report